Key Market Indicators
Sales of antihypertensive medicine in Canada are set to reach $108 million by 2026. In 2021, the country hit $102.4 million, a 1.3% annual growth rate since 2017. Australia surpassed Canada in 2021, reaching $102.4 million. Italy, Spain, and Australia came in second, third, and fourth place, respectively.
